227 related articles for article (PubMed ID: 35203419)
1. The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells.
Papadhimitriou SI; Terpos E; Liapis K; Pavlidis D; Marinakis T; Kastritis E; Dimopoulos MA; Tsitsilonis OE; Kostopoulos IV
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203419
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and laboratory parameters of plasma cell leukemia among Indian population.
Dubey H; Goel H; Verma S; Gupta S; Tanwar K; Rahul E; Kapoor G; Vasantharaman J; Ranjan A; Tanwar P; Chopra A
Am J Blood Res; 2022; 12(6):190-195. PubMed ID: 36742277
[TBL] [Abstract][Full Text] [Related]
3. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study.
Guan J; Ma J; Chen B
Hematology; 2023 Dec; 28(1):2254556. PubMed ID: 37732631
[TBL] [Abstract][Full Text] [Related]
4. Genetic aberrations and survival in plasma cell leukemia.
Tiedemann RE; Gonzalez-Paz N; Kyle RA; Santana-Davila R; Price-Troska T; Van Wier SA; Chng WJ; Ketterling RP; Gertz MA; Henderson K; Greipp PR; Dispenzieri A; Lacy MQ; Rajkumar SV; Bergsagel PL; Stewart AK; Fonseca R
Leukemia; 2008 May; 22(5):1044-52. PubMed ID: 18216867
[TBL] [Abstract][Full Text] [Related]
5. Genomics of Plasma Cell Leukemia.
Rojas EA; Gutiérrez NC
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326746
[TBL] [Abstract][Full Text] [Related]
6. Acquired del(9)(p22.3) in a primary plasma cell leukemia.
Achkar WA; Wafa A; Aljapawe A; Othman MA; Alhourani E; Liehr T
Mol Cytogenet; 2013 Aug; 6(1):33. PubMed ID: 23985162
[TBL] [Abstract][Full Text] [Related]
7. The Current State of Knowledge About Evolution of Multiple Myeloma to Plasma Cell Leukemia.
Jurczyszyn A; Olszewska-Szopa M; Vesole DH
Clin Lymphoma Myeloma Leuk; 2023 Mar; 23(3):188-193. PubMed ID: 36593169
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study.
Wang H; Zhou H; Zhang Z; Geng C; Chen W
Turk J Haematol; 2020 May; 37(2):91-97. PubMed ID: 31769277
[TBL] [Abstract][Full Text] [Related]
9. Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile.
Hofste Op Bruinink D; Kuiper R; van Duin M; Cupedo T; van der Velden VHJ; Hoogenboezem R; van der Holt B; Beverloo HB; Valent ET; Vermeulen M; Gay F; Broijl A; Avet-Loiseau H; Munshi NC; Musto P; Moreau P; Zweegman S; van de Donk NWCJ; Sonneveld P
J Clin Oncol; 2022 Sep; 40(27):3132-3150. PubMed ID: 35357885
[TBL] [Abstract][Full Text] [Related]
10. A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma.
Oliva S; De Paoli L; Ruggeri M; Caltagirone S; Troia R; Oddolo D; D'Agostino M; Gilestro M; Mina R; Saraci E; Margiotta Casaluci G; Genuardi E; Bringhen S; Boccadoro M; Omedé P
Ann Hematol; 2021 Feb; 100(2):437-443. PubMed ID: 33392702
[TBL] [Abstract][Full Text] [Related]
11. Genetic profile of primary plasma cell leukemia in Korea: comparison with plasma cell myeloma.
Lee Y; Yun J; Jeong D; Ryu S; Kwon SR; Yun H; Kim SM; Park JH; Lee DS
Leuk Lymphoma; 2022 Feb; 63(2):385-394. PubMed ID: 34592901
[TBL] [Abstract][Full Text] [Related]
12. Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients.
An G; Qin X; Acharya C; Xu Y; Deng S; Shi L; Zang M; Sui W; Yi S; Li Z; Hao M; Feng X; Jin F; Zou D; Qi J; Zhao Y; Tai YT; Wang J; Qiu L
Ann Hematol; 2015 Feb; 94(2):257-64. PubMed ID: 25231928
[TBL] [Abstract][Full Text] [Related]
13. Plasma cell leukemia in North India: retrospective analysis of a distinct clinicohematological entity from a tertiary care center and review of literature.
Bommannan K; Sachdeva MU; Malhotra P; Kumar N; Sharma P; Naseem S; Ahluwalia J; Das R; Varma N; Prakash G; Khadwal A; Srinivasan R; Varma S
Blood Res; 2016 Mar; 51(1):23-30. PubMed ID: 27104188
[TBL] [Abstract][Full Text] [Related]
14. Single-center experience of patients with plasma cell leukemia in the era of new therapeutics.
Dampmann M; Flossdorf S; Keyl J; Reinhardt HC; Hanoun C
Acta Haematol; 2024 May; ():. PubMed ID: 38763126
[TBL] [Abstract][Full Text] [Related]
15. Plasma cell leukemia: a rare condition.
Jiménez-Zepeda VH; Domínguez VJ
Ann Hematol; 2006 Apr; 85(4):263-7. PubMed ID: 16416115
[TBL] [Abstract][Full Text] [Related]
16. Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia.
Chang H; Qi X; Yeung J; Reece D; Xu W; Patterson B
Leuk Res; 2009 Feb; 33(2):259-62. PubMed ID: 18676019
[TBL] [Abstract][Full Text] [Related]
17. [Clinical Characteristics and Survival Analysis of Patients with Plasma Cell Leukemia].
Wang SF; Qin XQ; Guo QH; Wang JY; Ma YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):693-698. PubMed ID: 37356928
[TBL] [Abstract][Full Text] [Related]
18. Proteome alterations associated with transformation of multiple myeloma to secondary plasma cell leukemia.
Zatula A; Dikic A; Mulder C; Sharma A; Vågbø CB; Sousa MML; Waage A; Slupphaug G
Oncotarget; 2017 Mar; 8(12):19427-19442. PubMed ID: 28038447
[TBL] [Abstract][Full Text] [Related]
19. [Application Value of CD138 MACS-FISH in the Genetic Diagnosis of Plasma Cell Dyscrasia].
Mei JG; Li HQ; Cao HQ; Shao JJ; Zhai YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1437-1442. PubMed ID: 27784371
[TBL] [Abstract][Full Text] [Related]
20. Clinico-pathological spectrum of primary plasma cell leukemia diagnosed at a tertiary care centre in South India over 5 year period.
Kar R; Priyadarshini SG; Niraimathi M; Basu D; Badhe BA
Indian J Hematol Blood Transfus; 2012 Sep; 28(3):170-4. PubMed ID: 23997454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]